Risk Factors for Chalazion Diagnosis and Subsequent Surgical Excision

References

• Evans J, Vo KBH, Schmitt M. Chalazion: racial risk factors for formation, recurrence, and surgical intervention. Can J Ophthalmol. 2022 Aug;57(4):242–246. doi:10.1016/j.jcjo.2021.04.023.
   PubMed Web of Science ®Google Scholar
• Bipat R, Jiawan D, Toelsie JR. A case of recurrent chalazia associated with subclinical hypothyroidism. Case Rep Ophthalmol. 2020 May-Aug;11(2):212–216. doi:10.1159/000508603.
   PubMed Web of Science ®Google Scholar
• Patel S, Tohme N, Gorrin E, Kumar N, Goldhagen B, Galor A. Prevalence and risk factors for chalazion in an older veteran population. Br J Ophthalmol. 2022 Sep;106(9):1200–1205. doi:10.1136/bjophthalmol-2020-318420.
   PubMed Web of Science ®Google Scholar
• Alsoudi AF, Ton L, Ashraf DC, et al. Efficacy of care and antibiotic use for chalazia and hordeola. Eye Contact Lens. Apr 1 2022;48(4):162–168. doi:10.1097/ICL.0000000000000859.
   PubMed Web of Science ®Google Scholar
• Nascimento M, Wanzeler ACV, Sousa RLF, Satto LH, Padovani CR, Schellini SA. Chalazion and demographic characteristics of patients in a population sample. Revista Brasileira de Oftalmologia. 2015;74(4):222–224. doi:10.5935/0034-7280.20150045.
   Google Scholar
• Otulana T BO, Ajibode H, Ajibode HA. Chalazion, a Benign Eyelid Tumour – the Sagamu Experience. Niger J Ophthalmol. 2009;16(2). doi:10.5935/0034-7280.20150045.
   Google Scholar
• Nemet AY, Vinker S, Kaiserman I. Associated morbidity of chalazia. Cornea. Dec 2011;30(12):1376–1381. doi:10.1097/ICO.0b013e31821de36f.
   PubMed Web of Science ®Google Scholar
• Das AV, Dave TV. Demography and clinical features of chalazion among patients seen at a multi-tier eye care Network in India: an Electronic Medical Records Driven Big Data Analysis Report. Clin Ophthalmol. 2020;14:2163–2168. doi:10.2147/OPTH.S263146.
   PubMed Web of Science ®Google Scholar
• Stein JD, Blachley TS, Musch DC. Identification of persons with incident ocular diseases using health care claims databases. Am J Ophthalmol. 2013 Dec;156(6):1169–1175 e3. doi:10.1016/j.ajo.2013.06.035.
   PubMed Web of Science ®Google Scholar
• Shamloul G, Khachemoune A. An updated review of the sebaceous gland and its role in health and diseases Part 2: pathophysiological clinical disorders of sebaceous glands. Dermatol Ther. 2021 Mar;34(2):e14862. doi:10.1111/dth.14862.
   PubMed Web of Science ®Google Scholar
• Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity. J Invest Dermatol. 1979 Jul;73(1):108–111. doi:10.1111/1523-1747.ep12532792.
   PubMed Web of Science ®Google Scholar
• Orr P, Barron Y, Schein OD, Rubin GS, West SK. Eye care utilization by older Americans: the SEE Project. Salisbury Eye Evaluation. Ophthalmology. May 1999;106(5):904–909. doi:10.1016/s0161-6420(99)00508-4.
   PubMed Web of Science ®Google Scholar
• Lee DJ, Lam BL, Arora S, et al. Reported eye care utilization and health insurance status among US adults. Arch Ophthalmol Mar 2009;127(3):303–310. doi:10.1001/archophthalmol.2008.567.
   PubMedGoogle Scholar
• Lee JW, Yau GS, Wong MY, Yuen CY. A comparison of intralesional triamcinolone acetonide injection for primary chalazion in children and adults. ScientificWorldjournal. 2014;2014:413729. doi:10.1155/2014/413729.
   PubMedGoogle Scholar
• Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1054–1060. doi:10.1111/j.1468-3083.2010.03919.x.
   PubMed Web of Science ®Google Scholar
• Rasendran C, Tye G, Knusel K, Singh RP. Demographic and socioeconomic differences in outpatient ophthalmology utilization in the United States. Am J Ophthalmol. 2020 Oct;218:156–163. doi:10.1016/j.ajo.2020.05.022.
   PubMed Web of Science ®Google Scholar
• Lee CS, Su GL, Baughman DM, Wu Y, Lee AY, Bhattacharya S. Disparities in delivery of ophthalmic care; an exploration of public Medicare data. PLoS One. 2017;12(8):e0182598. doi:10.1371/journal.pone.0182598.
   PubMed Web of Science ®Google Scholar
• Lempert SL, Jenkins MS, Brown SI. Chalazia and rosacea. Arch Ophthalmol. 1979 Sep;97(9):1652–1653. doi:10.1001/archopht.1979.01020020220006.
   PubMedGoogle Scholar
• Wladis EJ, Adam AP. Treatment of ocular rosacea. Surv Ophthalmol. 2018 May-Jun;63(3):340–346. doi:10.1016/j.survophthal.2017.07.005.
   PubMed Web of Science ®Google Scholar
• Vazirnia A, Wat H, Danesh MJ, Anderson RR. Intense pulsed light for improving dry eye disease in rosacea. J Am Acad Dermatol. 2020 Aug;83(2):e105. doi:10.1016/j.jaad.2019.11.045.
   PubMed Web of Science ®Google Scholar
• Wang CY, Ho RW, Fang PC, et al. The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study. BMC Ophthalmol. Apr 12 2018;18(1):90. doi:10.1186/s12886-018-0763-9.
   PubMedGoogle Scholar
• Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011 Mar;52(4):1938–1978. doi:10.1167/iovs.10-6997c.
   PubMed Web of Science ®Google Scholar
• Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015 Dec;36(4):669–683. doi:10.1016/j.ccm.2015.08.009.
   PubMed Web of Science ®Google Scholar
• Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldjournal. 2015;2015:438402. doi:10.1155/2015/438402.
   PubMedGoogle Scholar
• Wu AY, Gervasio KA, Gergoudis KN, Wei C, Oestreicher JH, Harvey JT. Conservative therapy for chalazia: is it really effective? Acta Ophthalmol. 2018 Jun;96(4):e503–509. doi:10.1111/aos.13675.
   PubMed Web of Science ®Google Scholar